Clinical Research Sites for the NIAAA Medications Development Clinical Investigations Network for the Treatment of Alcohol Use Disorder
Award Notice Posted
- Solicitation number
- 75N94021D00010
- Agency
-
National Institute of Child Health and Human Development
National Institutes of Health, Department of Health and Human Services
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 75N94021D00010 Federal IDV award
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Place of performance
- Charlottesville VA 22903 USA
Notice details come from SAM.gov. Updated .
About this opportunity
This Indefinite Delivery, Indefinite Quantity contract was awarded by the National Institute on Alcohol Abuse and Alcoholism to the Rector & Visitors of the University of Virginia to establish a clinical research site within the NIAAA Medications Development Clinical Investigations Network for the Treatment of Alcohol Use Disorder. The purpose of the Network is to expedite discovery of promising new treatments for Alcohol Use Disorder through the conduct of multiple-site Phase II clinical trials and related clinical research. The University of Virginia was awarded $48,000,000 to participate in the Network managed by the National Institutes of Health National Institute of Child Health and Human Development on behalf of NIAAA.
Notice text
This Research and Development contract was awarded on behalf of the National Institute on Alcohol Abuse and Alcoholism (NIAAA) and is one of multiple Indefinite Delivery, Indefinite Quantity contracts awarded for clinical research sites to participate in the NIAAA Medications Development Clinical Investigations Network for the Treatment of Alcohol Use Disorder. The purpose of these contracts is to establish and utilize a Network of clinical research sites to expedite discovery of promising new treatments for Alcohol Use Disorder for the conduct of multiple-site Phase II clinical trials and clinical research leading to Phase II clinical trials.
This contract was awarded on the basis of full and open competition.
Awarded contract 75N94021D00010 to RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA for 48000000.00 on 2021-03-15.
Notice history
6 of 11 notices listed here. See the rest on GovTribe.
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity